NASDAQ: ONC
Beone Medicines Ltd Stock Ownership - Who owns Beone Medicines?

Insider buying vs selling

Have Beone Medicines Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Baker Bros Advisors LPDirector2026-09-1430,768$36.83
$1.13MBuy
Baker Bros Advisors LPDirector2026-09-1430,768$36.83
$1.13MBuy
Xiaodong 1. WangDirector2026-09-0810,688$349.28
$3.73MSell
Xiaodong 1. WangDirector2026-09-0831,027$36.90
$1.14MBuy
Xiaodong 1. WangDirector2026-09-086,278$351.25
$2.21MSell
Xiaodong 1. WangDirector2026-09-081,517$347.39
$526.99kSell
Xiaodong 1. WangDirector2026-09-081,181$345.38
$407.90kSell
Xiaodong 1. WangDirector2026-09-081,721$348.01
$598.93kSell
Xiaodong 1. WangDirector2026-09-082,841$346.16
$983.43kSell
Xiaodong 1. WangDirector2026-09-086,569$350.27
$2.30MSell

1 of 25

ONC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ONC insiders and whales buy or sell their stock.

ONC Shareholders

What type of owners hold Beone Medicines Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hillhouse Capital Advisors Ltd9.95%147,035,258$53.96BInsider
Hhlr Advisors Ltd8.46%125,045,741$45.89BInsider
Hillhouse Capital Management Ltd7.50%110,866,146$40.69BInsider
Cb Biotech Investment Ltd1.33%19,601,138$7.19BInsider
Amgen Inc1.28%18,943,802$6.95BInsider
Baker Bros Advisors LP0.56%8,229,962$3.02BInsider
Merck Co Inc0.54%7,942,314$2.91BInsider
Xiaodong Wang0.37%5,491,395$2.02BInsider
Xiaodong 1. Wang0.31%4,588,213$1.68BInsider
Donald W. Glazer0.19%2,756,633$1.01BInsider

1 of 3

ONC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONC0.00%30.90%Net SellingNet Selling
RVMD0.10%9.00%Net SellingNet Selling
ALNY0.10%20.79%Net Selling
RPRX0.06%17.99%Net SellingNet Selling
ROIV0.08%92.24%Net SellingNet Selling

Beone Medicines Stock Ownership FAQ

Who owns Beone Medicines?

Beone Medicines (NASDAQ: ONC) is owned by 0.00% institutional shareholders, 30.90% Beone Medicines insiders, and 69.10% retail investors. Hillhouse Capital Advisors Ltd is the largest individual Beone Medicines shareholder, owning 147.04M shares representing 9.95% of the company. Hillhouse Capital Advisors Ltd's Beone Medicines shares are currently valued at $53.71B.

If you're new to stock investing, here's how to buy Beone Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.